Christian Carsten Silverster Kunz

Title: Christian Carsten Silverster Kunz: Innovator in Immunology

Introduction

Christian Carsten Silverster Kunz is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunology, particularly through his work on Interleukin-18 (IL-18) binding molecules. With a total of 2 patents, his innovations are poised to impact therapeutic and diagnostic applications in autoimmune and inflammatory diseases.

Latest Patents

Kunz's latest patents focus on IL-18 binding molecules. Interleukin-18 plays a crucial role in both innate and acquired immunity. The bioactivity of IL-18 is negatively regulated by the IL-18 binding protein (IL18BP), which inhibits its biological activity by forming a complex with free IL-18. The inventions disclosed by Kunz include binding molecules, particularly antibodies or fragments, that specifically bind IL-18 without interacting with the IL-18/IL-18BP complex. These binding molecules have potential applications as therapeutic agents for treating IL-18-related autoimmune and inflammatory diseases, as well as diagnostic tools for measuring IL-18 levels.

Career Highlights

Christian Carsten Silverster Kunz is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development in immunology, contributing to advancements in medical science.

Collaborations

Kunz has collaborated with notable colleagues, including Michael Otto Bardroff and Barbara Brannetti. These collaborations have enriched his research and expanded the scope of his innovations.

Conclusion

Christian Carsten Silverster Kunz is a prominent inventor whose work on IL-18 binding molecules holds promise for advancing therapeutic and diagnostic approaches in immunology. His contributions are significant in the ongoing fight against autoimmune and inflammatory diseases.